Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2012 / Cilt: 9 - Sayı: 2

Tubo-ovarian abscess: Risk factors for failed response to conservative treatment

Tubo-ovaryan abse: Konzervatif tedavi başarızlığındaki risk faktörleri

Pages
106–109
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The duration of hospitalization was significantly shorter in group A (8,21 ± 1,9)(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To define the epidemiologic, clinical and laboratory risk factors associated with failed response to conservative antibiotic therapy in tubo-ovarian abscess (TOA).
📊
Key Findings & Data:Material and methods: The charts of 108 patients, admitted with clinically and sonographically diagnosed TOA between 1988 and 2010 were reviewed.
💡
Conclusion & Impact:The duration of hospitalization was significantly shorter in group A (8,21 ± 1,9)(p
🔬Design:Review & Systematic Survey
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: To define the epidemiologic, clinical and laboratory risk factors associated with failed response to conservative antibiotic therapy in tubo-ovarian abscess (TOA). Material and methods: The charts of 108 patients, admitted with clinically and sonographically diagnosed TOA between 1988 and 2010 were reviewed. On admission, all patients were treated with broad-spectrum antibiotics, and were divided into two groups according to the response to medical treatment. 47 patients, responding to antibiotic therapy, constituted group A, whereas 61 patients who did not respond and were further treated by surgery, were included in group B. The groups were compared with respect to patient characteristics, clinical and sonographic presentation, laboratory findings. Results: There was no statistical difference between the mean age of patients (38±2,8) responding to medical therapy (group A) and the age of patients who did not respond (group B) (38±3,4)(p>0,05). The gravidity, parity, use of intrauterin device (IUD) and history of tubal ligation were similar between the groups (p>0,05). The size and bilaterality of TOA, evaluated sonographically were significantly increased in group B compared with group A (p=0,008 and p=0,002, respectively). On admisson, fever >38,0°C was determined in %32 of group B and %8 of group A (p=0,003.) The only laboratory finding differentiating between two groups was C-reactive protein (CRP), being significantly higher in group B (p=0,03). The duration of hospitalization was significantly shorter in group A (8,21 ± 1,9)(p

Özet

Amaç: Retrospektif olarak, konzervatif tedaviye yanıt vermeyen tubo-ovaryan abse (TOA) olgularındaki epidemiyolojik, klinik ve laboratuar risk faktörlerini belirlemek. Gereç ve yöntemler: 1988-2010 yılları arasında, klinik ve sonografik olarak TOA tanısı almış 108 hastanın dosyası retrospektif olarak incelendi. Hastaların hepsine ilk olarak geniş spektrumlu antibiyotik tedavisi başlanmıştı ve hastalar medikal tedaviye yanıtına göre 2 gruba ayrıldı. Antibiyotik tedavisine yanıt veren 47 (%43) hasta grup A, yanıt vermeyen ve sonrasında opere edilen 61 (%57) hasta ise grup B olarak belirlendi. Gruplar hastaların demografik, klinik ve sonografik bulguları, laboratuar değerlerine göre kıyaslandı. Bulgular: Medikal tedaviye yanıt veren hastaların (grup A) ortalama yaşı (38±2,8) ve yanıt vermeyen hastaların (grup B) ortalama yaşı (38±3,4) arasında fark bulunmadı (p>0,05). Benzer şekilde hastaların ortalama gravide ve pariteleri, rahimiçi araç (R‹A) kullanımı ve tüp ligasyonu açısından da istatistiksel fark görülmedi (p>0,05). TOA boyutu (p=0,008) ve absenin bilateral olması (p=0,002) cerrahi yapılan grupta anlamlı olarak daha fazla bulundu. Başvuru anında ateş; grup B'de %32, grup A'da ise %8 hastada tesbit edildi (p=0,003). Grup B'de daha yüksek olmak üzere iki grup arasinda anlamlı olan tek laboratuar değeri C-reaktif protein (CRP) olarak bulundu (p=0,03). Hospitalizasyon süresi grup A'da daha kısa idi (8,21 ± 1,9) (p

🔖

Cite This Article

KURU, O., BERKMAN, S., SAYGILI, H., ŞEN, S. (2022). Tubo-ovarian abscess: Risk factors for failed response to conservative treatment. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 9 - Sayı: 2, 106–109. https://ajindex.com/articles/631570

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Franklin EW 3rd, Hevron JE Jr, Thompson JD.''Management of the pelvic abscess'' Clinical Obstetrics and Gynecology, vol.16, pp.66- 79, 1973.
  2. Ginsburg DS, Stern JL, et al., ''Tubo-ovarian abscess: a retrospective review'' American Journal of Obstetrics and Gynecology, vol.138, no.7, pp.1055- 8, 1980.
  3. Washington AE, Aral SO, Wolner-Hanssen P et al. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991; 266: 2581- 6. Clark JFJ, Moore-Hines S. A study of tubo-ovarian abscess at Howard University Hospital (1965 through 1975). J Nat Med Assoc 1979; 71: 1109- 11. Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Practice & Research Clinical Obstetrics and Gynaecology 23 (2009) 667- 78. Fleischer AC. Entman SS. Differential diagnosis of pelvic masses: in Chervenak FA, Isaacson GC. Cambell S (eds): Ultrasound in Obstetrics and Gynecology. Boston. Little. Brown. 1975. p 1650. Centers for Disease Control and Prevention, Sexually Transmitted Diseases Treatment Guidelines, 2010.
  4. McNutt LA, Wu C, Xue X and Hafner JP, ''Estimating the relative risk in cohort studies and clinical trials of common outcomes'' The American Journal of Epidemiology, vol 157, no.10, pp.940-943, 2003.
  5. Mc Neeley SG, Heendrix SL, Mazzoni MM et al. Medically sound, cost effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998; 178: 1272- 8. Kaplan AL, Jacobs WM & Ehresman JB. Agressive management of pelvic abscess. Am J Obstet Gynecol 1967; 98: 482- 7. Karakulak M, Pala G, Ayd›n Y, Saatl› B, Güçlü S. Tuboovaryan Abseli Olgular›n De¤erlendirilmesi. DEÜ T›p Fakültesi Dergisi Cilt 22, Say› 1, Nisan 2008 Sf:9- 13. Gjelland K, Ekerhovd E & Granberg S. Transvaginal ultrasound- guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. Am J Obstet Gynecol 2005; 193: 1323- 30. Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tubo-ovarian abscess: Comparison of broad spectrum β-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991; 164: 1556- 62. Perez-Medina T, Huertas MA, Bajo JM. Early ultrasound- guided transvaginal drainage of tubo-ovarian abscess: A randomized study. Ultrasound Obstet Gynecol 1996; 7: 435- 8. Halperin R, Levinson O, Yaron M, Bukovsky I, Schneider D. Tubo-ovarian abscess in older women: Is the woman's age a risk factor for failed response to conservative treatment? Gynecol Obstet Invest 2003; 55: 211- 5.